Recombinant IL2RA (Camidanlumab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-IL2RA (Camidanlumab Biosimilar) antibody has been validated for ELISA. It is suitable to detect IL2RA (Camidanlumab Biosimilar) in samples from Human.
Catalog No. ABIN7487884
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant IL2RA (Camidanlumab Biosimilar) antibody (ABIN7487884)
Target
IL2RA (Camidanlumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL2RA (Camidanlumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Camidanlumab Biosimilar - Anti-IL2RA, CD25 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL2RA (Camidanlumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
ADCT-301(unconjugated),HuMax-TAC-ADC
Camidanlumab Tesirine (ADCT-301) is an antibody drug conjugate (ADC), composed of the human monoclonal antibody, HuMax-TAC, which is directed against human CD25. The antibody is conjugated through a protease cleavable linker to SG3199, a pyrrolobenzodiazepine (PBD) dimer cytotoxin. -
CAS-No
- 921618-45-3
Target
-
You are here:
